Answers are grounded in this paper and cite their sources.
-THC and cannabidiol (CBD). Cannabis contains over 140 phytocannabinoids, although only a handful have been tested for pharmacological activity. Many of these minor cannabinoids potently modulate receptors, ionotropic channels, and enzymes associated with the ECS and show therapeutic potential individually or synergistically with other phytocannabinoids. The following review will focus on the pharmacological developments of the next generation of phytocannabinoid therapeutics.
No takes yet. Share an insight, caveat, or question.
Peter B. Sampson (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: